Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.12

(-2%)

FLWS

$3.06

(-1.76%)

ACCO

$2.98

(1.19%)

ARLP

$28.54

(-0.56%)

AUIAF

$0.13

(-2.17%)

AZZ

$127.78

(2.67%)

BTBT

$1.58

(1.94%)

BTM

$2.56

(-8.75%)

CVKD

$5.03

(-12.22%)

LCE:CA

$0.38

(4.11%)

COCP

$1.08

(1.89%)

CDRO

$8.6

(5.13%)

CVGI

$3.66

(-1.35%)

LODE

$3.23

(16.01%)

CMTL

$3.61

(1.69%)

CNDT

$1.23

(-2%)

CXW

$20.09

(0.75%)

CMLS

$0.01

(0%)

DRCT

$0.82

(-0.24%)

DLHC

$6.25

(5.75%)

SSP

$3.56

(2.89%)

ELDN

$2.92

(1.21%)

EVC

$3.1

(-1.12%)

EDRY

$19.38

(-2.76%)

ESEA

$62.91

(-7.47%)

FAT

$0.16

(0%)

RAIL

$8.06

(0.06%)

GDEV

$13.33

(0%)

GOVX

$1.55

(0.65%)

GOCO

$1.77

(-10.23%)

GHM

$85.5

(0.67%)

GLDD

$16.97

(0%)

GYRE

$7.73

(0.52%)

HMENF

$1.98

(1.54%)

III

$3.91

(-0.76%)

IPOOF

$12.81

(-0.6%)

KELYA

$8.75

(1.27%)

KTOS

$78.88

(1.79%)

LUCK

$8.04

(0%)

MAIA

$1.48

(2.78%)

MGROF

$0.41

(4.4%)

NTRB

$3.86

(2.93%)

OCGN

$1.97

(2.6%)

PERF

$1.67

(-0.6%)

QMCI

$0.14

(0%)

RGP

$3.67

(-1.21%)

SGA

$11.95

(-0.08%)

SHWZ

(0%)

SHIP

$12.82

(-3.97%)

SLQT

$0.62

(-2.06%)

SKYX

$1.61

(-2.12%)

SNAL

$0.57

(2.52%)

GEO

$17.48

(3.19%)

ODP

$28

(0%)

TNXP

$15.06

(-1.83%)

TSQ

$5.69

(1.43%)

TZOO

$6.37

(3.23%)

UNCY

$6.67

(4.38%)

VVX

$69.81

(1.82%)

VNCE

$2.11

(-2.31%)

XELB

$1.52

(1.67%)

ZOMDF

$0.12

(-2%)

FLWS

$3.06

(-1.76%)

channelchek-in

‌

3/25/2026

Merck Bets $6.7 Billion on a Former Microcap’s CML Drug — TERN Investors Reap the Reward

Merck (NYSE: MRK) announced Tuesday it has entered into a definitive agreement to acquire Terns Pharmaceuticals (Nasdaq: TERN), a clinical-stage oncology company, for $53.00 per share in cash — representing an approximate equity value of $6.7 billion, or roughly $5.7 billion net of acquired cash. The deal carries a 31% premium to Terns’ 60-day volume-weighted average price and a 42% premium to its 90-day VWAP as of March 24, 2026.

3 min read